HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdataset

by Joseph R. McGill, Vijaya L. Simhadri, Zuben E. Sauna
Published 2021-05-01

Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population

by Vijaya L. Simhadri, Joseph McGill, Shane McMahon, Junxia Wang, Haiyan Jiang, Zuben E. Sauna
Published 2018-09-01

Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4+ T-cells

by Vijaya L. Simhadri, Louis Hopkins, Joseph R. McGill, Brian R. Duke, Swati Mukherjee, Kate Zhang, Zuben E. Sauna
Published 2021-08-01

Recent advances in (therapeutic protein) drug development [version 1; referees: 2 approved]

by H.A. Daniel Lagassé, Aikaterini Alexaki, Vijaya L. Simhadri, Nobuko H. Katagiri, Wojciech Jankowski, Zuben E. Sauna, Chava Kimchi-Sarfaty
Published 2017-02-01

Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene.

by Tewarit Sarachana, Neetu Dahiya, Vijaya L Simhadri, Gouri Shankar Pandey, Surbhi Saini, Christine Guelcher, Michael F Guerrera, Chava Kimchi-Sarfaty, Zuben E Sauna, Chintamani D Atreya
Published 2015-01-01